Thomas G. Auchincloss - Jun 9, 2022 Form 4 Insider Report for CONCERT PHARMACEUTICALS, INC. (CNCE)

Role: Director
Signature: /s/ Jeffrey A. Munsie, attorney-in-fact
Stock symbol: CNCE
Transactions as of: Jun 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/13/2022, 04:13 PM
Previous filing: Jun 6, 2022
Next filing: Mar 6, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNCE	Common Stock	Award		+16.4K	+93.05%		34K	Jun 9, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
F2	Not applicable.

Content

Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.

Not applicable.